Literature DB >> 12064601

The regulatory role of the C-terminal domain of connexin43.

J L Shin1, J L Solan, P D Lampe.   

Abstract

The C-terminal (CT) domain of connexin43 (Cx43) is thought to be important in the control of gap junction function via: a.) CT phosphorylation-dependent control of gap junction assembly and gating, b.) interactions of CT with key regulatory binding partners. To more closely examine CT-dependent regulation, we have expressed a hemagglutinin-Cx43CT (amino acids 235-382) fusion protein in Normal Rat Kidney (NRK) cells under a tetracycline-responsive inducible promoter. Western blot analysis shows that Cx43CT expression is markedly induced by at least 48 h oftreatment with the tetracycline analogue, doxycycline. Furthermore, Cx43CT is modified within the cell, as several treatments/conditions that increase endogenous Cx43 phosphorylation induced a mobility shift in Cx43CT. Treatment with kinase activators, including epidermal growth factor (EGF) and the tumor promoting phorbol ester 12-O-tetradecanylphorbol-13-acetate (TPA), caused a shift in the mobility of the Cx43CT in a manner consistent with the mobility shift observed upon increased phosphorylation of endogenous Cx43. Similarly, Cx43CT in mitotic cells is extensively shifted, consistent with reports which show that Cx43 is phosphorylated to a unique phosphoisoform in mitotic cells. These results indicate that the Cx43CT can interact with at least some of the kinases that phosphorylate endogenous Cx43 in cells and possibly modulate the effects of kinase activation on gap junctional communication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12064601     DOI: 10.3109/15419060109080736

Source DB:  PubMed          Journal:  Cell Commun Adhes        ISSN: 1543-5180


  9 in total

1.  Regulation of Cx37 channel and growth-suppressive properties by phosphorylation.

Authors:  Nicole L Jacobsen; Tasha K Pontifex; Hanjun Li; Joell L Solan; Paul D Lampe; Paul L Sorgen; Janis M Burt
Journal:  J Cell Sci       Date:  2017-08-17       Impact factor: 5.285

2.  Selectivity of connexin 43 channels is regulated through protein kinase C-dependent phosphorylation.

Authors:  Jose F Ek-Vitorin; Timothy J King; Nathanael S Heyman; Paul D Lampe; Janis M Burt
Journal:  Circ Res       Date:  2006-05-18       Impact factor: 17.367

3.  Caveolin-1 and -2 interact with connexin43 and regulate gap junctional intercellular communication in keratinocytes.

Authors:  Stéphanie Langlois; Kyle N Cowan; Qing Shao; Bryce J Cowan; Dale W Laird
Journal:  Mol Biol Cell       Date:  2007-12-27       Impact factor: 4.138

4.  Regulation of gap junctional charge selectivity in cells coexpressing connexin 40 and connexin 43.

Authors:  Nathanael S Heyman; David T Kurjiaka; Jose F Ek Vitorin; Janis M Burt
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-22       Impact factor: 4.733

5.  Serine 319 phosphorylation is necessary and sufficient to induce a Cx37 conformation that leads to arrested cell cycling.

Authors:  Samantha-Su Z Taylor; Nicole L Jacobsen; Tasha K Pontifex; Paul Langlais; Janis M Burt
Journal:  J Cell Sci       Date:  2020-06-18       Impact factor: 5.285

6.  Connexin43 functions as a novel interacting partner of heat shock cognate protein 70.

Authors:  Tomoya Hatakeyama; Ping Dai; Yoshinori Harada; Hitoshi Hino; Fujiko Tsukahara; Yoshiro Maru; Eigo Otsuji; Tetsuro Takamatsu
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 7.  Role of ROS/RNS in Preeclampsia: Are Connexins the Missing Piece?

Authors:  María F Rozas-Villanueva; Paola Casanello; Mauricio A Retamal
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 8.  Pathogenicity-associated protein domains: The fiercely-conserved evolutionary signatures.

Authors:  Seema Patel
Journal:  Gene Rep       Date:  2017-04-08

9.  The C-terminal domain of connexin43 modulates cartilage structure via chondrocyte phenotypic changes.

Authors:  Raquel Gago-Fuentes; John F Bechberger; Marta Varela-Eirin; Adrian Varela-Vazquez; Benigno Acea; Eduardo Fonseca; Christian C Naus; Maria D Mayan
Journal:  Oncotarget       Date:  2016-11-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.